5-Aza-2′-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair

Nucleic Acids Research

Volumn 41, Issue 11, 2013, Pages 5827-5836

  Orta, Manuel Luís ^a   Calderón Montaño, José Manuel ^a   Domínguez, Inmaculada ^a   Pastor, Nuria ^a   Burgos Morón, Estefanía ^a   López Lázaro, Miguel ^a   Cortés, Felipe ^a   Mateos, Santiago ^a   Helleday, Thomas ^b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b SCIENCE FOR LIFE LABORATORY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ATR PROTEIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DNA METHYLTRANSFERASE 1; FANCONI ANEMIA GROUP G PROTEIN; HISTONE H2AX; RAD51 PROTEIN;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CHROMATID EXCHANGE; CHROMOSOME ANALYSIS; COLONY FORMATION; CONTROLLED STUDY; DNA CROSS LINKING; DNA DAMAGE; DNA END JOINING REPAIR; DNA METHYLATION; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; DNA SYNTHESIS; ENZYME INHIBITION; FANCONI ANEMIA; HOMOLOGOUS RECOMBINATION; NONHUMAN; PRIORITY JOURNAL; RECOMBINATION REPAIR; SIGNAL TRANSDUCTION;

ANIMALS; AZACITIDINE; CELL LINE; CHROMATIDS; CRICETINAE; CRICETULUS; DNA BREAKS; DNA REPLICATION; DNA-ACTIVATED PROTEIN KINASE; ENZYME INHIBITORS; FANCONI ANEMIA COMPLEMENTATION GROUP G PROTEIN; LEUPEPTINS; PROTEASOME INHIBITORS; RECOMBINATIONAL DNA REPAIR;

EID: 84878834721     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt270     Document Type: Article

References (44)

1. Robertson, K.D. (2001) DNA methylation, methyltransferases, and cancer. Oncogene, 20, 3139-3155.
2. Christman, J.K. (2002) 5-azacytidine and 5-aza-20-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene, 21, 5483-5495.
3. Palii, S.S., Van Emburgh, B.O., Sankpal, U.T., Brown, K.D. and Robertson, K.D. (2008) DNA methylation inhibitor 5-aza-20-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol. Cell. Biol., 28, 752-771.
4. Juttermann, R., Li, E. and Jaenisch, R. (1994) Toxicity of 5-aza-20-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc. Natl Acad. Sci. USA, 91, 11797-11801.
5. Schermelleh, L., Spada, F., Easwaran, H.P., Zolghadr, K., Margot, J.B., Cardoso, M.C. and Leonhardt, H. (2005) Trapped in action: direct visualization of DNA methyltransferase activity in living cells. Nat. Methods, 2, 751-756.
6. Weisenberger, D.J., Velicescu, M., Cheng, J.C., Gonzales, F.A., Liang, G. and Jones, P.A. (2004) Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation. Cancer Cell, 2, 62-72.
7. Herman, J.G. and Baylin, S.B. (2003) Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med., 349, 2042-2054.
8. Jones, P.A. and Baylin, S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
9. Yang, A.S., Doshi, K.D., Choi, S.W., Mason, J.B., Mannari, R.K., Gharybian, V., Luna, R., Rashid, A., Shen, L., Estecio, M.R. et al. (2006) DNA methylation changes after 5-aza-20-deoxycytidine therapy in patients with leukemia. Cancer Res., 66, 5495-5503.
10. Klimek, V.M., Dolezal, E.K., Tees, M.T., Devlin, S.M., Stein, K., Romero, A. and Nimer, S.D. (2012) Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromes. Leuk Res., 36, 1093-1097.
11. Kennedy, A.W. and Hart, W.R. (1982) Multiple squamous-cell carcinomas in fanconi's anemia. Cancer, 50, 811-814.
12. Alter, B.P. (2003) Cancer in fanconi anemia, 1927-2001. Cancer, 97, 425-440.
13. Collins, N. and Kupfer, G.M. (2005) Molecular pathogenesis of fanconi anemia. Int. J. Hematol., 82, 176-183.
14. Bagby, G.C. Jr. (2003) Genetic basis of fanconi anemia. Curr. Opin. Hematol., 10, 68-76.
15. Joenje, H. and Patel, K.J. (2001) The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet., 2, 446-457.
16. D'Andrea, A.D. (2003) The fanconi road to cancer. Genes Dev., 17, 1933-1936.
17. Lyakhovich, A. and Surralles, J. (2006) Disruption of the fanconi anemia/BRCA pathway in sporadic cancer. Cancer Lett., 232, 99-106.
18. Tebbs, R.S., Hinz, J.M., Yamada, N.A., Wilson, J.B., Salazar, E.P., Thomas, C.B., Jones, I.M., Jones, N.J. and Thompson, L.H. (2005) New insights into the fanconi anemia pathway from an isogenic FancG hamster CHO mutant. DNA Repair, 4, 11-22.
19. Corte?s, F., Morgan, W.F. and Wolff, S. (1987) Effect of exogenous thymidine on sister-chromatid exchange frequency in Chinese hamster ovary cells with bromodeoxyuridine-and chlorodeoxyuridine-substituted chromosomes. Mutat. Res., 192, 277-282.
20. Kiziltepe, T., Hideshima, T., Catley, L., Raje, N., Yasui, H., Shiraishi, N., Okawa, Y., Ikeda, H., Vallet, S., Pozzi, S. et al. (2007) 5-azacytidine, a DNA methyltransferase inhibitor, induces ATRmediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells. Mol. Cancer Ther., 6, 1718-1727.
21. Elvers, I., Johansson, F., Groth, P., Erixon, K. and Helleday, T. (2011) UV stalled replication forks restart by re-priming in human fibroblasts. Nucleic Acids Res., 39, 7049-7057.
22. Petermann, E., Orta, M.L., Issaeva, N., Schultz, N. and Helleday, T. (2010) Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol. Cell, 37, 492-502.
23. Groth, P., Orta, M.L., Elvers, I., Majumder, M.M., Lagerqvist, A. and Helleday, T. (2012) Homologous recombination repairs secondary replication induced DNA double-strand breaks after ionizing radiation. Nucleic Acids Res., 40, 6585-6594.
24. Orta, M.L., Mateos, S., Cantero, G., Wolff, L.J. and Cortes, F. (2008) Protection of halogenated DNA from strand breakage and sister-chromatid exchange induced by the topoisomerase I inhibitor camptothecin. Mutat. Res., 637, 40-48.
25. Helleday, T. (2003) Pathways for mitotic homologous recombination in mammalian cells. Mutat. Res., 532, 103-115.
26. Arnaudeau, C., Lundin, C. and Helleday, T. (2001) DNA doublestrand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J. Mol. Biol., 307, 1235-1245.
27. Deans, A.J. and West, S.C. (2011) DNA interstrand crosslink repair and cancer. Nat. Rev. Cancer., 11, 467-480.
28. Jacquemont, C. and Taniguchi, T. (2007) Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Cancer Res., 67, 7395-7405.
29. Murakawa, Y., Sonoda, E., Barber, L.J., Zeng, W., Yokomori, K., Kimura, H., Niimi, A., Lehmann, A., Zhao, G.Y., Hochegger, H. et al. (2007) Inhibitors of the proteasome suppress homologous DNA recombination in mammalian cells. Cancer Res., 67, 8536-8543.
30. Lundin, C., Erixon, K., Arnaudeau, C., Schultz, N., Jenssen, D., Meuth, M. and Helleday, T. (2002) Different roles for nonhomologous end joining and homologous recombination following replication arrest in mammalian cells. Mol. Cell. Biol., 22, 5869-5878.
31. Lundin, C., Schultz, N., Arnaudeau, C., Mohindra, A., Hansen, L.T. and Helleday, T. (2003) RAD51 is involved in repair of damage associated with DNA replication in mammalian cells. J. Mol. Biol., 328, 521-535.
32. Adamo, A., Collis, S.J., Adelman, C.A., Silva, N., Horejsi, Z., Ward, J.D., Martinez-Perez, E., Boulton, S.J. and La Volpe, A. (2010) Preventing nonhomologous end joining suppresses DNA repair defects of fanconi anemia. Mol. Cell, 39, 25-35.
33. Strumberg, D., Pilon, A.A., Smith, M., Hickey, R., Malkas, L. and Pommier, Y. (2000) Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 50-phosphorylated DNA double-strand breaks by replication runoff. Mol. Cell. Biol., 20, 3977-3987.
34. Petermann, E. and Helleday, T. (2010) Pathways of mammalian replication fork restart. Nat. Rev. Mol. Cell Biol., 11, 683-687.
35. Smogorzewska, A., Matsuoka, S., Vinciguerra, P., McDonald, E.R. III, Hurov, K.E., Luo, J., Ballif, B.A., Gygi, S.P., Hofmann, K., D'Andrea, A.D. et al. (2007) Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell, 129, 289-301.
36. Mailand, N., Bekker-Jensen, S., Faustrup, H., Melander, F., Bartek, J., Lukas, C. and Lukas, J. (2007) RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell, 131, 887-900.
37. van der Heijden, M.S., Brody, J.R., Dezentje, D.A., Gallmeier, E., Cunningham, S.C., Swartz, M.J., DeMarzo, A.M., Offerhaus, G.J., Isacoff, W.H., Hruban, R.H. et al. (2005) In vivo therapeutic responses contingent on fanconi anemia/BRCA2 status of the tumor. Clin. Cancer Res., 11, 7508-7515.
38. Chen, Q., Van der Sluis, P.C., Boulware, D., Hazlehurst, L.A. and Dalton, W.S. (2005) The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells. Blood, 106, 698-705.
39. San Miguel, J.F., Schlag, R., Khuageva, N.K., Dimopoulos, M.A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M.T., Palumbo, A., Samoilova, O.S. et al. (2008) Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N. Engl. J. Med., 359, 906-917.
40. Helleday, T. (2010) Homologous recombination in cancer development, treatment and development of drug resistance. Carcinogenesis, 31, 955-960.
41. Blum, W., Schwind, S., Tarighat, S.S., Geyer, S., Eisfeld, A.K., Whitman, S., Walker, A., Klisovic, R., Byrd, J.C., Santhanam, R. et al. (2012) Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia. Blood, 119, 6025-6031.
42. Gustafsson, B., Moell, J., Leblanc, K., Barbany, G., So? derháll, S. and Winiarski, J. (2012) Donor cell-derived acute myeloid leukemia after second allogenic cord blood transplantation in a patient with Fanconi anemia. Pediatr. Transplant., 16, 241-245.
43. Kraakman-van der Zwet, M., Overkamp, W.J., van Lange, R.E., Essers, J., van Duijn-Goedhart, A., Wiggers, I., Swaminathan, S., van Buul, P.P., Errami, A., Tan, R.T. et al. (2002) Brca2 (XRCC11) deEciency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol. Cell. Biol., 22, 669-679.
44. Castillo, P., Bogliolo, M. and Surralles, J. (2011) Coordinated action of the Fanconi anemia and ataxia telangiectasia pathways in response to oxidative damage. DNA Repair, 10, 518-525.